Johns Hopkins Medicine: Experimental Cancer Drug Eliminates Bone Metastases Caused by Breast Cancer in Lab Models
October 16, 2024
October 16, 2024
BALTIMORE, Maryland, Oct. 16 (TNSres) -- Johns Hopkins Medicine issued the following news release:
In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown to help treat other types of cancer and viral illnesses.
Patients with breast cancer and bone metastasis have limited treatment options and often rely on palliative care to ea . . .
In a new study led by Johns Hopkins Medicine, the drug RK-33 has demonstrated promise in treating breast cancer that has spread to the bone (breast cancer bone metastasis). RK-33 was previously shown to help treat other types of cancer and viral illnesses.
Patients with breast cancer and bone metastasis have limited treatment options and often rely on palliative care to ea . . .